Is Sermorelin FDA Approved? Geref, Compounding and What It Means

"Is sermorelin FDA approved?" is one of the most common questions people ask before a growth-hormone-axis conversation, and the honest answer has three parts: sermorelin was FDA-approved, the approved product is no longer marketed, and the sermorelin available today through telehealth is compounded — which is a different regulatory category altogether. Understanding those three parts is what lets you ask a clinician the right questions.

The short answer

Sermorelin acetate was FDA-approved under the brand name Geref in the 1990s, for diagnosing growth hormone deficiency (GHD) in children and for treating GHD. The branded product was later discontinued — for manufacturing and commercial reasons rather than safety findings — after recombinant growth hormone changed the clinical landscape. Today, sermorelin is available only as a compounded medication, prepared to order at state-licensed 503A pharmacies under an individual clinician's prescription. Compounded sermorelin is not an FDA-approved drug product.

That distinction matters because "FDA-approved" describes a specific product, formulation and indication that went through the agency's review — not the molecule in the abstract.

What sermorelin is

Sermorelin is a 29-amino-acid peptide corresponding to the first 29 amino acids of endogenous growth-hormone-releasing hormone (GHRH 1-29). It binds GHRH receptors on the anterior pituitary and stimulates the body's own growth-hormone synthesis and release, rather than supplying growth hormone directly. Because the pituitary's normal feedback loops remain intact, GH release follows the body's natural pulsatile pattern — a mechanistic distinction from exogenous growth hormone that clinicians often raise when discussing this pathway. Its effectiveness depends on functional pituitary reserve, which is one reason clinical review comes first.

For the evidence behind those statements, see the sermorelin evidence summary.

Approved once, discontinued, now compounded: what each status means

Formerly approved (Geref). The approval covered a specific product and specific uses in growth hormone deficiency. It did not cover the recovery, sleep, or body-composition conversations in which sermorelin is most often discussed today; those remain off-label discussions.

Discontinued. A discontinued brand is not the same as a withdrawn-for-safety brand. The product left the market for commercial reasons. That history is part of why sermorelin has decades of clinical use and a well-described mechanism, and also why its modern, indication-specific trial data is thinner than newer molecules such as tesamorelin.

Compounded (today). Compounded medications are prepared to order for an individual patient by a state-licensed 503A pharmacy. They are not commercially manufactured, and they are not evaluated through the same FDA review process as commercially manufactured drugs. State boards of pharmacy are the primary regulators, and sterile compounding must follow USP standards such as USP <797>. The compounded vs. branded medications guide explains the differences in detail.

What "compounded, not FDA-approved" means for you

It does not mean unregulated. It does mean the responsibility for quality sits with the compounding pharmacy's quality system and the state board that licenses it, rather than with a federal pre-market approval. Practical questions worth asking any provider:

• Which state-licensed 503A pharmacy prepares the medication, and can the provider name it?
• Does the pharmacy perform potency and sterility testing on finished preparations, and can a certificate of analysis be requested?
• Is the clinical review performed by an independent licensed clinician who screens for contraindications and monitors response (for example, IGF-1)?
• Are claims kept to what the evidence supports, without "FDA-approved" language attached to a compounded product?

New Blue Health publishes a compounding and off-label disclosure describing how its partner pharmacies are selected and overseen; partner pharmacies maintain quality systems and may perform sterility and potency testing depending on the medication and pharmacy policies. The compounded source verification checklist turns the questions above into a worksheet.

How this compares with tesamorelin

Tesamorelin is the GHRH analog with the clearer current regulatory record: the active ingredient is FDA-approved as Egrifta SV for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. Compounded tesamorelin, like compounded sermorelin, is prepared at 503A pharmacies and is not the approved product. The tesamorelin vs. sermorelin comparison walks through structure, evidence and safety side by side.

Safety considerations

Both sermorelin and tesamorelin are generally well tolerated in published studies, but neither is without risk. Commonly reported side effects include injection-site reactions, headache and transient flushing; because they raise GH and IGF-1, theoretical dose-dependent effects such as joint pain, fluid retention and carpal-tunnel-like symptoms are also described. Long-term safety data for compounded GHRH analogs in healthy adults is limited, which is why IGF-1 monitoring and clinician follow-up are advisable rather than optional.

How a clinician-guided sermorelin pathway works

New Blue Health is a technology and administrative services platform — not a medical provider. It coordinates intake, payment and logistics; an independent licensed clinician reviews each case and decides whether sermorelin is appropriate. Not everyone qualifies. If prescribed, the medication is prepared by a state-licensed 503A pharmacy and shipped directly to you. Pricing is one all-in price with the clinical consultation included; current prices and term options are on the sermorelin guide. If a clinician determines that a prescription is not appropriate, the medication cost is refunded; the consultation terms are set out in the refund policy.

Frequently Asked Questions

Is sermorelin FDA approved right now?

No. Sermorelin was previously FDA-approved as Geref for growth hormone deficiency, but that product is discontinued. The sermorelin available through telehealth today is compounded at state-licensed 503A pharmacies and is not an FDA-approved drug product.

Why was Geref discontinued?

The branded product was discontinued for manufacturing and commercial reasons after recombinant growth hormone became the standard for growth hormone deficiency — not because of a safety withdrawal.

Is compounded sermorelin legal?

Compounding pursuant to an individual prescription by a state-licensed 503A pharmacy is a regulated practice overseen by state boards of pharmacy. What is not permitted is marketing a compounded product as FDA-approved, or selling it without a prescription.

Does "not FDA-approved" mean it is unsafe?

It means the product has not gone through federal pre-market review. Safety in practice depends on the pharmacy's quality system, the clinician's screening and monitoring, and honest expectations about the evidence. Discuss contraindications and monitoring with a licensed clinician before starting.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All clinical decisions should be made by a licensed clinician based on individual patient evaluation. New Blue Health is a technology and administrative services platform, not a medical provider. Individual results vary, and eligibility for any pathway depends on clinical review.